Human DECR1 Alexa Fluor® 700-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # AF7976N
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Met233-Ser335
Accession # Q16698
Specificity
Clonality
Host
Isotype
Applications for Human DECR1 Alexa Fluor® 700-conjugated Antibody
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
Background: DECR1
DECR-1 (2, 4-DiEnol CoA Reductase, mitochondrial) is a 33-36 kDa member of the DECR subfamily, short-chain dehydrogenase/reductase family of molecules. It is a mitochondrial enzyme that is expressed in multiple cell types, particularly those involved in oxidative degradation of fatty acids. Fatty acids provide energy following their degradation by four enzymes that comprise the beta-oxidation cycle. The optimal configuration for fatty acids in this cycle is one of saturation. However, many fatty acids that appear before this cycle are unsaturated, and it is necessary to transform them into a suitable configuration for processing. DECR-1 converts a two double-bonded substrate into a one double-bonded substrate, which subsequently undergoes isomerization and entry into the beta-oxidation cycle. Human DECR-1 is 335 amino acids (aa) in length. It contains a mitochondrial targeting sequence (aa 1-34), and a 301 aa mature region that possesses one catalytic site (aa 57-302). There are two potential acetylation sites at Lys110 and Lys230. DECR-1 forms homotetramers. One potential isoform variant shows an alternative start site at Met93 coupled to a deletion of aa 292-335. Over aa 233-335, human DECR-1 shares 87% aa sequence identity with mouse DECR-1.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional DECR1 Products
Product Specific Notices for Human DECR1 Alexa Fluor® 700-conjugated Antibody
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only